Lead an expanding hepatology program and advance an asset through late-stage development while exploring life-cycle management opportunities.
Provide medical and scientific leadership for a hepatology asset, driving strategy to achieve clinical, regulatory, and commercial milestones.
Oversee design, initiation, execution, and closure of late-stage clinical trials including Phase 3 studies to deliver high-quality data for regulatory approval and commercialization.
Lead global regulatory activities including dossier submissions, preparation for meetings with health authorities (FDA, EMA, PMDA), and responses to regulatory queries.
Identify, develop, and execute life-cycle management strategies to expand the asset beyond its primary indication.
Collaborate across clinical, translational, commercial, regulatory, and scientific cross-functional teams within a complex matrix.
Monitor emerging trends, competitor activities, and advancements in hepatology to identify differentiation and strategic growth opportunities.
Lead and mentor a high-performing team, fostering professional development and alignment with GSK values and objectives.
Act as an external representative of GSK's RIIRU in hepatology, engaging with stakeholders, scientific forums, and professional organizations.
Requirements
Medical degree and clinical medical specialty training board qualification/registration.
Experience in the global pharmaceutical/biotechnology industry in the field of hepatology.
Experience in clinical research and drug development, with a focus on hepatology.
Line-management experience overseeing medical directors and/or clinical scientists and leading matrix teams within a clinical development setting.
Experience in late-stage hepatology drug development, including Phase 2 and Phase 3 clinical trial design, initiation, execution, and closure.
Preferred: Medical degree and clinical medical specialty training board qualification/registration in Gastroenterology or Hepatology.
Preferred: Demonstrated success in life-cycle management, including indication expansion and strategic development beyond primary indications.
Preferred: Experience with regulatory interactions, including submissions, strategy meetings, and negotiations with health authorities.
Preferred: Understanding of the clinical and scientific landscape in hepatology and experience in advancing innovative therapies.
Preferred: Experience in translational medicine and biomarker development.
Requirement: On-site office presence (minimum of two days a week) in one of GSK’s US (PA or MA) or UK (London - New Oxford Street or Stevenage) sites.
Benefits
Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.
ATS Keywords
Tip: use these terms in your resume and cover letter to boost ATS matches.